BPGbio Presents Key Advances in its Oncology Pipeline related to the NAi Interrogative Biology Platform
BPGbio, and Cresa Announce 70,000-sq.-ft. Lease at 300 Third Avenue in Waltham
BPGbio Appoints Ritesh Srivastava as General Counsel
BPGbio Presents Updated Phase 2a Clinical Results Demonstrating Benefit of BPM31510 in Combination with Chemotherapy in Pancreatic Cancer at ASCO GI
BPGbio Announces Phase 2 BPM31510 Glioblastoma Trial-in-Progress Update
BPGbio Wins BioTech Breakthrough Award for Therapeutics Platform of The Year
BPGbio Highlights AI-Developed Late-Stage Therapeutics Assets
BPGbio to Share Updates in Development of Late-Stage AI-Developed Therapeutic Pipeline at the Pharma Partnering Summit
BPGbio Appoints Vijay Modur, M.D., Ph.D., as SVP & Chief Medical Officer
BPGbio Announces Commercial Availability of NAi, BPGbio’s Pioneering Interrogative Biology Platform